Apellis Pharmaceuticals sees stock surge on strong drug revenues, but AI may offer more upside
ago 1 mois
HEALTH

Apellis Pharmaceuticals sees stock surge on strong drug revenues, but AI may offer more upside

You are using the web version

For a smoother, faster experience with real-time alerts, discover the BeeFiny Android app.

You can continue on the web version

Keywords

# Apellis Pharmaceuticals# healthcare stocks# biopharmaceutical# SYFOVRE# EMPAVELI

You might also like

POET Technologies Forges Partnerships to Advance AI Optical Interconnects
TECHNOLOGY

POET Technologies Forges Partnerships to Advance AI Optical Interconnects

ago 1 mois
Rackspace Technology Launches UK Sovereign Cyber Recovery Cloud with Rubrik
TECHNOLOGY

Rackspace Technology Launches UK Sovereign Cyber Recovery Cloud with Rubrik

ago 1 mois
Unity Software Raises Revenue Outlook Driven by Strong Vector Business Performance
TECHNOLOGY

Unity Software Raises Revenue Outlook Driven by Strong Vector Business Performance

ago 1 mois
AI Startup Backed by NVIDIA Seeks Billions in Funding
TECHNOLOGY

AI Startup Backed by NVIDIA Seeks Billions in Funding

ago 1 mois
Pharma Giant Eli Lilly Partners with AI Firm for New Medicines
TECHNOLOGY

Pharma Giant Eli Lilly Partners with AI Firm for New Medicines

ago 1 mois